⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL287612 | 1.00 | — | — | |
| SCHEMBL287613 | 1.00 | — | — | |
| SCHEMBL29222987 | 0.89 | ALDH1A1 (0.40) | — | |
| SCHEMBL164110 | 0.82 | — | — | |
| Diisopropanolamine SCHEMBL29053431 | 0.81 | CYP2D6 (0.42) | — | |
| Adipic Acid SCHEMBL14965585 | 0.81 | LMNA (0.50) | — | |
| SCHEMBL7179855 | 0.81 | KDM4E (0.41) | — | |
| SCHEMBL28833553 | 0.81 | ALDH1A1 (0.39) | — | |
| SCHEMBL22043850 | 0.81 | ALDH1A1 (0.39) | — | |
| Hydrochloric Acid SCHEMBL5886752 | 0.80 | CYP2D6 (0.48) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12391799-B2 | Peptoid polymers and methods of use | X-THERMA, INC. (US) | 2025-08-19 | — | — | US | disclosed |
| US-20250185646-A1 | NOVEL SUPERCOOLING METHODS FOR PRESERVATION OF BIOLOGICAL SAMPLES | X-THERMA, INC. (US) | 2025-06-12 | — | — | US | disclosed |
| US-12207647-B2 | Supercooling methods for preservation of biological samples | X-THERMA, INC. (US) | 2025-01-28 | — | — | US | disclosed |
| CN-110730786-B | Peptoid polymers and methods of use | 先时迈纳米生物科技股份有限公司 | 2025-01-07 | — | — | CN | disclosed |
| CN-118680161-A | Novel supercooling method for preserving biological samples | 先时迈纳米生物科技股份有限公司 | 2024-09-24 | — | — | CN | disclosed |
| CN-110769689-B | Novel supercooling method for preserving biological samples | 先时迈纳米生物科技股份有限公司 | 2024-04-26 | — | — | CN | disclosed |
| EP-3609906-B1 | NOVEL PEPTOID POLYMERS AND METHODS OF USE | X THERMA INC (US) | 2024-03-20 | — | — | EP | disclosed |
| US-20240084074-A1 | NOVEL PEPTOID POLYMERS AND METHODS OF USE | X-THERMA, INC. (US) | 2024-03-14 | — | — | US | disclosed |
| US-20230292741-A1 | NOVEL SUPERCOOLING METHODS FOR PRESERVATION OF BIOLOGICAL SAMPLES | X-THERMA, INC. (US) | 2023-09-21 | — | — | US | disclosed |
| US-20230292741-A1 | NOVEL SUPERCOOLING METHODS FOR PRESERVATION OF BIOLOGICAL SAMPLES | X-THERMA, INC. (US) | 2023-09-21 | — | — | US | disclosed |
| US-11564388-B2 | Supercooling methods for preservation of biological samples | X-THERMA, INC. (US) | 2023-01-31 | — | — | US | disclosed |
| US-20200239632-A1 | NOVEL PEPTOID POLYMERS AND METHODS OF USE | X-THERMA, INC. (US) | 2020-07-30 | — | — | US | disclosed |
| US-20200239632-A1 | NOVEL PEPTOID POLYMERS AND METHODS OF USE | X-THERMA, INC. (US) | 2020-07-30 | — | — | US | disclosed |
| US-20200170241-A1 | NOVEL SUPERCOOLING METHODS FOR PRESERVATION OF BIOLOGICAL SAMPLES | X-THERMA, INC. (US) | 2020-06-04 | — | — | US | disclosed |
| US-20200170241-A1 | NOVEL SUPERCOOLING METHODS FOR PRESERVATION OF BIOLOGICAL SAMPLES | X-THERMA, INC. (US) | 2020-06-04 | — | — | US | disclosed |
| CN-110769689-A | Novel supercooling method for preserving biological samples | 先时迈纳米生物科技股份有限公司 | 2020-02-07 | — | — | CN | disclosed |
| CN-110730786-A | Novel peptoid polymers and methods of use | 先时迈纳米生物科技股份有限公司 | 2020-01-24 | — | — | CN | disclosed |
| US-6656946-B2 | For treating diseases, particularly tumoral diseases, diseases of the lungs and respiratory tract | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2003-12-02 | — | — | US | disclosed |
| US-20020082271-A1 | Aminoquinazolines which inhibit signal transduction mediated by tyrosine kinases | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2002-06-27 | — | — | US | disclosed |
| US-6403580-B1 | HAVING AN INHIBITORY EFFECT ON SIGNAL TRANSDUCTION MEDIATED BY TYROSINE KINASES, THE USE THEREOF FOR TREATING DISEASES, PARTICULARLY TUMORAL DISEASES, DISEASES OF THE LUNGS AND RESPIRATORY TRACT, AND THE PREPARATION THEREOF. | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2002-06-11 | — | — | US | disclosed |